Fulgent Genetics (FLGT) Return on Sales (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales eased to 0.0% in Q1 2026 per FLGT's latest filing, from 0.92% in the prior quarter.
• The five-year high for Return on Sales was 0.92% in Q4 2025, with the low at 0.0% in Q1 2026.
• Average Return on Sales over 5 years is 0.05%, with a median of 0.0% recorded in 2024.
• Year-over-year, Return on Sales dropped 1 bps in 2022 and soared 92 bps in 2025.
• Fulgent Genetics' Return on Sales stood at 0.0% in 2022, then jumped by 35 bps to 0.0% in 2023, then slumped by 104 bps to 0.0% in 2024, then surged by 672978 bps to 0.92% in 2025, then slumped by 100 bps to 0.0% in 2026.
• Business Quant data shows FLGT's Return on Sales at 0.0% in Q1 2026, 0.92% in Q4 2025, and 0.0% in Q3 2025.